GO:0005682 U5 snRNP: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0005682 (U5 snRNP) is a cellular_component term describing a ribonucleoprotein complex built on the U5 small nuclear RNA, a heptameric Sm ring, and U5-specific proteins such as PRPF8, SNRNP200, EFTUD2, PRPF6, PRPF31, and TSSC4.
• The U5 snRNP is a core subunit of the spliceosome and is required for recognition of the 5' splice site and exon ligation during pre-mRNA splicing.
• Its biogenesis is a stepwise, chaperone-controlled process in which AAR2, Ecd, and neurochondrin regulate the release and stability of PRPF8.
• U5 snRNP components are directly linked to human disease, including retinitis pigmentosa (PRPF8, PRPF31, SNRNP200) and other spliceosomopathies with tissue-specific phenotypes.
• Beyond splicing, U5 snRNP core proteins contribute to antiviral defense through programmed cell death and interferon induction.
• CRISPR knockout, point-mutation, knock-in, and overexpression models combined with RNA-seq, proteomics, and structural methods are the standard toolkit for dissecting U5 snRNP function.
Description
The U5 small nuclear ribonucleoprotein (U5 snRNP), annotated as GO:0005682, is one of the essential building blocks of the spliceosome, the molecular machine that removes introns from pre-messenger RNA. It is defined as a ribonucleoprotein complex containing the U5 small nuclear RNA, a heptameric ring of Sm proteins, and several proteins unique to U5 that remain associated with the U5 snRNA both when the particle is free and when it is assembled into spliceosomal complexes. Because the U5 snRNP sits at the catalytic heart of the spliceosome, its composition and assembly are of central interest to researchers studying gene expression, RNA processing, and human disease. Recent structural and biochemical work has transformed our understanding of how the human U5 snRNP is built and recycled. Cryo-electron microscopy structures of the human 20S U5 snRNP and of late biogenesis intermediates have revealed the architecture of the particle and the ordered handover of assembly factors such as AAR2 and TSSC4. These studies show that U5 snRNP maturation is not a passive process but is actively regulated by dedicated chaperones and assembly factors, including Ecd and neurochondrin, which control the stability and release of the central scaffold protein PRPF8. For biomedical researchers, GO:0005682 is more than a structural annotation. Mutations in U5 snRNP genes cause tissue-specific spliceosomopathies, most notably retinal degeneration, and U5 core proteins also participate in antiviral responses and programmed cell death. This makes the U5 snRNP a compelling target for functional genomics, CRISPR modeling, and therapeutic development, and it explains why the term is heavily used in transcriptomics, proteomics, and structural biology workflows.
U5 snRNP At A Glance
| GO ID | GO:0005682 |
|---|---|
| GO term | U5 snRNP |
| Ontology | cellular_component |
| Synonym | snRNP U5 |
| Major function | Core spliceosomal ribonucleoprotein complex required for pre-mRNA splicing and exon ligation |
| RNA component | U5 small nuclear RNA (U5 snRNA) |
| Core protein ring | Heptameric Sm protein ring |
| Signature proteins | PRPF8, SNRNP200, EFTUD2, PRPF6, PRPF31, and other U5-specific factors |
| Assembly factors | AAR2, Ecd, neurochondrin, TSSC4 |
| Disease relevance | Retinitis pigmentosa and other spliceosomopathies; antiviral defense |
What Is GO:0005682?
In plain terms, GO:0005682 describes the U5 snRNP: a molecular machine made of one small RNA (U5 snRNA), a ring of seven Sm proteins, and a set of U5-specific proteins that stay with the RNA whether the particle is free or plugged into the spliceosome. The QuickGO definition emphasizes three features: the U5 snRNA, the heptameric Sm ring, and the unique proteins that remain associated with U5 snRNA across spliceosomal complexes. Functionally, this complex is a core component of the spliceosome and is required for pre-mRNA splicing.
Why Is U5 snRNP Important in Cell Biology?
The U5 snRNP is important because it is a non-redundant core component of the spliceosome, the machine that processes nearly every human pre-mRNA. Without a functional U5 snRNP, cells cannot efficiently recognize the 5' splice site or catalyze exon ligation, and mutations in its components cause human disease with striking tissue specificity, especially in the retina. At the same time, U5 snRNP proteins have been implicated in antiviral defense and programmed cell death, linking this complex to immunology and cell-death biology. For researchers, GO:0005682 therefore provides a precise annotation for interpreting transcriptomic, proteomic, and structural datasets, and a rational entry point for CRISPR-based disease modeling.
• The U5 snRNP is a core spliceosomal subunit required for pre-mRNA splicing and exon ligation.
• Mutations in U5 snRNP genes such as PRPF8, PRPF31, and SNRNP200 cause retinitis pigmentosa and related spliceosomopathies.
• U5 snRNP biogenesis is regulated by dedicated assembly factors including AAR2, Ecd, neurochondrin, and TSSC4.
• U5 snRNP core proteins contribute to antiviral defense via programmed cell death and interferon induction.
• Transcriptome-wide splicing networks reveal specialized regulatory functions for core spliceosome components, including U5 factors.
• Structural studies of the human 20S U5 snRNP provide a template for interpreting disease mutations.
• U5 snRNP genes are attractive targets for CRISPR knockout, point-mutation, and knock-in disease models.
• The complex is a useful benchmark for RNA-protein interaction proteomics and cryo-EM workflows.
• Tissue-specific spliceosomopathy phenotypes make U5 snRNP a model for understanding genotype-phenotype relationships.
• U5 snRNP annotation supports functional interpretation of cancer and neurodegeneration transcriptomes.
What Happens During U5 snRNP?
Biogenesis and maturation of the U5 snRNP
In simple terms: The cell builds the U5 snRNP step by step, using helper proteins to assemble and stabilize its core.
U5 snRNP biogenesis is a stepwise process in which the U5 snRNA and Sm ring are assembled with U5-specific proteins, and assembly factors are sequentially released. The central scaffold PRPF8 must be properly folded and stabilized, and its release from the assembly factor AAR2 is a regulated step. Ecd promotes U5 snRNP maturation and PRPF8 stability, while neurochondrin promotes maturation by regulating AAR2 release from PRPF8. TSSC4 is a U5 snRNP component that promotes tri-snRNP formation, linking late biogenesis to spliceosome assembly. Together, these studies define a chaperone-controlled maturation pathway for the human U5 snRNP.
Integration into the spliceosome and catalysis
In simple terms: Once built, the U5 snRNP plugs into the spliceosome and helps cut and join RNA pieces.
The U5 snRNP is a core subunit of the spliceosome and is required for recognition of the 5' splice site and for exon ligation during pre-mRNA splicing. Transcriptome-wide analyses show that core spliceosome components, including U5 factors, have specialized regulatory functions rather than acting uniformly on all introns. Structural studies of the human 20S U5 snRNP and late biogenesis intermediates provide the framework for understanding how U5 components rearrange during catalytic activation and recycling.
Structure and composition of the U5 snRNP
In simple terms: The U5 snRNP is a molecular machine with an RNA core, a protein ring, and several large signature proteins.
The complex contains the U5 snRNA, a heptameric Sm protein ring, and U5-specific proteins that remain associated with the U5 snRNA both when the particle is free and when it is assembled into spliceosomal complexes. Cryo-EM structures of the human 20S U5 snRNP reveal the architecture of the particle and the positions of major proteins such as PRPF8, SNRNP200, and EFTUD2. Late biogenesis and recycling structures show how assembly factors are exchanged and how the particle is remodeled. TSSC4 is a component of the U5 snRNP that promotes tri-snRNP formation.
Molecular mechanism and regulation
In simple terms: Helper proteins act like quality-control inspectors that decide when the U5 snRNP is ready to work.
The molecular mechanism of U5 snRNP function depends on regulated protein-protein and protein-RNA interactions. AAR2 release from PRPF8 is a key maturation step, and neurochondrin regulates this release to promote U5 snRNP maturation. Ecd promotes U5 snRNP maturation and PRPF8 stability, indicating that folding and stability of the scaffold are actively controlled. TSSC4 promotes tri-snRNP formation, coupling late U5 biogenesis to spliceosome assembly. These regulatory layers ensure that only properly assembled U5 snRNPs enter the splicing cycle.
Non-splicing roles in antiviral defense
In simple terms: U5 snRNP proteins also help cells fight viruses by triggering cell death and interferon responses.
U5 snRNP core proteins are key components of the defense response against viral infection through their roles in programmed cell death and interferon induction. This expands the functional scope of GO:0005682 beyond canonical splicing and highlights the value of studying U5 factors in infection and immunity models.
Key Genes Involved in GO:0005682 U5 snRNP
The following genes and proteins are core or regulatory components of the U5 snRNP (GO:0005682) and are frequently studied in functional and disease research.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PRPF8 | Central scaffold protein of the U5 snRNP; stabilized during maturation | Mutations cause retinitis pigmentosa; key target for structural and disease studies |
| SNRNP200 | U5-specific ATPase/RNA helicase involved in spliceosome dynamics | Associated with retinal degeneration; studied by cryo-EM and functional assays |
| EFTUD2 | U5-specific GTPase component of the spliceosome | Linked to spliceosomopathies; used in structural and interaction studies |
| PRPF6 | U5-specific protein involved in tri-snRNP formation | Candidate for functional and disease modeling studies |
| PRPF31 | U5-associated protein required for spliceosome assembly | Major retinitis pigmentosa gene; model for tissue-specific spliceosomopathy |
| TSSC4 | U5 snRNP component promoting tri-snRNP formation | Studied for late biogenesis and spliceosome assembly |
| AAR2 | Assembly factor regulating PRPF8 release during maturation | Target for understanding U5 snRNP quality control |
| ECD | Promotes U5 snRNP maturation and PRPF8 stability | Studied in maturation and stability assays |
| NCDN (neurochondrin) | Regulates AAR2 release from PRPF8 to promote maturation | Emerging regulator of U5 snRNP biogenesis |
| Sm proteins (SNRPB, SNRPD1, SNRPD2, SNRPD3, SNRPE, SNRPF, SNRPG) | Form the heptameric Sm ring of the U5 snRNP | Core structural components used in assembly and interaction studies |
| U5 snRNA | Non-coding RNA scaffold of the U5 snRNP | Central to structural and functional studies of the complex |
| PRPF4 | U5-associated splicing factor | Used in transcriptome-wide splicing network analyses |
| PRPF3 | U5-associated splicing factor | Studied in splicing regulation and disease contexts |
| PRPF38A | Spliceosomal factor with specialized regulatory functions | Analyzed in core spliceosome perturbation studies |
| SNRPB2 | U5-associated small nuclear ribonucleoprotein | Used in splicing network and proteomics studies |
| DDX23 | Spliceosomal RNA helicase associated with U5 function | Studied in spliceosome dynamics and regulation |
| SART1 | Tri-snRNP factor linked to U5 integration | Investigated in spliceosome assembly studies |
| USP39 | Spliceosomal factor with specialized regulatory roles | Analyzed in transcriptome-wide splicing networks |
How Is U5 snRNP Regulated?
U5 snRNP biogenesis and function are regulated at multiple levels. The release of the assembly factor AAR2 from PRPF8 is a controlled step, and neurochondrin regulates this release to promote U5 snRNP maturation. Ecd promotes U5 snRNP maturation and PRPF8 stability, indicating that scaffold quality control is an active regulatory node. TSSC4 promotes tri-snRNP formation, coupling late U5 biogenesis to spliceosome assembly. At the functional level, transcriptome-wide analyses show that core spliceosome components, including U5 factors, have specialized regulatory functions rather than acting uniformly on all introns. These layers of regulation help explain why U5 snRNP perturbations produce gene-specific and tissue-specific splicing defects.
U5 snRNP and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PRPF8 | Retinitis pigmentosa and spliceosomopathy | CRISPR knock-in of patient mutations in retinal cell models |
| PRPF31 | Retinitis pigmentosa with tissue-specific penetrance | Knockout and point-mutation models in photoreceptor-like cells |
| SNRNP200 | Retinal degeneration linked to spliceosome dysfunction | Knock-in and overexpression models for structural and functional studies |
| EFTUD2 | Spliceosomopathy with developmental phenotypes | Knockout and point-mutation models in stem cell-derived systems |
| U5 core proteins | Antiviral defense and interferon induction | Knockout models in infection and cell-death assays |
U5 snRNP spliceosomopathies and retinal degeneration
Mutations in U5 snRNP genes cause spliceosomopathies with prominent retinal phenotypes. The tissue specificity of U5 snRNP spliceosomopathies is an active area of research, and genes such as PRPF8, PRPF31, and SNRNP200 are established disease genes. Because the U5 snRNP is a core spliceosomal subunit, its dysfunction leads to widespread but gene-specific splicing changes that can be mapped by transcriptome-wide approaches.
U5 snRNP in antiviral defense and cell death
U5 snRNP core proteins are key components of the defense response against viral infection through their roles in programmed cell death and interferon induction. This links GO:0005682 to immunology and cell-death biology, and suggests that U5 factors may be relevant to viral pathogenesis and host-directed antiviral strategies.
U5 snRNP and specialized splicing regulation in disease
Transcriptome-wide splicing network studies reveal that core spliceosome components, including U5 factors, have specialized regulatory functions. This means that U5 snRNP perturbations can selectively affect disease-relevant transcripts, providing a mechanistic basis for interpreting cancer and neurodegeneration transcriptomes.
From U5 snRNP-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a U5 snRNP gene required for cell viability and splicing? | CRISPR knockout cell lines |
| Does a patient variant impair U5 snRNP assembly or function? | CRISPR point-mutation knock-in models |
| Can a tagged U5 protein be used to purify the complex? | Tagged knock-in (e.g., GFP/HA) cell lines |
| Does overexpression of a U5 factor rescue a splicing defect? | Overexpression cell models |
| How does loss of a U5 assembly factor affect the transcriptome? | Knockout plus RNA-seq and splicing network analysis |
| What is the structural impact of a disease mutation? | Knock-in models combined with cryo-EM and proteomics |
How to Study the U5 snRNP Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global changes in gene expression and splicing | Splicing network analysis after U5 factor perturbation |
| Cryo-EM | Three-dimensional structure of the U5 snRNP | Structural interpretation of disease mutations |
| Affinity purification mass spectrometry | Protein composition and interactions | Mapping assembly factor exchange |
| Western blot | Protein stability, e.g., PRPF8 levels | Testing maturation factor function |
| Immunofluorescence | Subcellular localization of U5 components | Assessing nuclear localization and assembly |
| Splicing reporter assays | Splicing efficiency of specific transcripts | Testing the impact of U5 mutations |
| CRISPR screening | Fitness and splicing phenotypes of U5 genes | Identifying disease-relevant dependencies |
| Interferon and cell-death assays | Antiviral and programmed cell death responses | Studying non-splicing roles of U5 proteins |
Transcriptome-wide splicing analysis
RNA-seq and transcriptome-wide splicing network approaches are used to define how U5 snRNP perturbations change splicing. These methods reveal specialized regulatory functions of core spliceosome components and identify gene-specific splicing defects caused by U5 factor loss.
Structural biology of the U5 snRNP
Cryo-electron microscopy has been used to determine the structure of the human 20S U5 snRNP and late biogenesis intermediates, providing a framework for interpreting disease mutations and assembly pathways.
Proteomics and interaction studies
Affinity purification and mass spectrometry are used to define the protein composition of the U5 snRNP and to track assembly factor exchange, including AAR2, Ecd, neurochondrin, and TSSC4.
Functional assays for maturation and stability
Biochemical and cell-based assays are used to measure PRPF8 stability, AAR2 release, and tri-snRNP formation, allowing researchers to test the roles of Ecd, neurochondrin, and TSSC4 in U5 snRNP maturation.
How CRISPR Can Be Used to Study GO:0005682 U5 snRNP
Knockout
CRISPR knockout of U5 snRNP genes is used to test requirement for cell viability, splicing, and disease-relevant phenotypes. Knockout models help define which transcripts depend on specific U5 factors and can be combined with RNA-seq to build splicing networks.
Point Mutation
Point-mutation knock-in models are used to study patient variants in U5 snRNP genes, such as those found in retinitis pigmentosa. These models allow researchers to separate loss-of-function, hypomorphic, and dominant effects on assembly and splicing.
Knock-in
Tagged knock-in of U5 proteins enables purification and imaging of the complex. Knock-in of epitope or fluorescent tags supports proteomics, cryo-EM, and live-cell localization studies of the U5 snRNP.
Overexpression
Overexpression models are used to test whether increased levels of U5 assembly factors such as Ecd or neurochondrin can rescue maturation or stability defects. These experiments help define rate-limiting steps in U5 snRNP biogenesis.
How EDITGENE Supports U5 snRNP Research
Researchers studying U5 snRNP-related genes often need to determine whether a candidate gene is causally involved in splicing, assembly, or disease, and which model system best captures the relevant phenotype. EDITGENE provides the CRISPR and functional genomics tools needed to move from candidate gene to mechanistic insight.
Contact EDITGENE today to design your custom CRISPR model for U5 snRNP research.
Frequently Asked Questions About U5 snRNP
What is GO:0005682?
GO:0005682 is the Gene Ontology cellular_component term for the U5 snRNP, a ribonucleoprotein complex containing U5 snRNA, a heptameric Sm ring, and U5-specific proteins.
What is the U5 snRNP?
The U5 snRNP is a core spliceosomal complex built on U5 snRNA that is required for pre-mRNA splicing and exon ligation.
What genes are involved in the U5 snRNP?
Key genes include PRPF8, SNRNP200, EFTUD2, PRPF6, PRPF31, TSSC4, and Sm protein genes, along with assembly factors such as AAR2, ECD, and NCDN.
What does the U5 snRNP do in splicing?
It is required for recognition of the 5' splice site and for exon ligation during pre-mRNA splicing.
How is the U5 snRNP assembled?
It is assembled stepwise with the help of assembly factors, including AAR2, Ecd, neurochondrin, and TSSC4, which control PRPF8 stability and release.
Which diseases are linked to U5 snRNP mutations?
Mutations in U5 snRNP genes cause spliceosomopathies with prominent retinal phenotypes, including retinitis pigmentosa.
Does the U5 snRNP have non-splicing roles?
Yes, U5 snRNP core proteins contribute to antiviral defense through programmed cell death and interferon induction.
What methods are used to study the U5 snRNP?
Common methods include RNA-seq, cryo-EM, affinity purification mass spectrometry, western blot, and CRISPR-based perturbation.
How can CRISPR help study U5 snRNP genes?
CRISPR knockout, point-mutation, knock-in, and overexpression models allow researchers to test gene function, variant effects, and rescue hypotheses.
Why is the U5 snRNP important for researchers?
It is a non-redundant core spliceosome component linked to human disease and antiviral defense, making it central to RNA biology and therapeutic research.
Conclusion
GO:0005682 (U5 snRNP) defines a core spliceosomal ribonucleoprotein complex whose assembly, structure, and regulation are now understood in increasing molecular detail. Its central role in pre-mRNA splicing and its links to retinal disease and antiviral defense make it a high-value target for functional genomics and CRISPR modeling. Researchers can now combine structural, transcriptomic, proteomic, and CRISPR approaches to dissect U5 snRNP biology and translate findings into disease insight.
References
- 1. Kemal RA et al.. 2025. Addressing the tissue specificity of U5 snRNP spliceosomopathies.. Front Cell Dev Biol 13:1572188 PMID: 40264708
- 2. Rogalska ME et al.. 2024. Transcriptome-wide splicing network reveals specialized regulatory functions of the core spliceosome.. Science 386(6721):551-560 PMID: 39480945
- 3. Schneider S et al.. 2024. Structure of the human 20S U5 snRNP.. Nat Struct Mol Biol 31(5):752-756 PMID: 38467877
- 4. Erkelenz S et al.. 2021. Ecd promotes U5 snRNP maturation and Prp8 stability.. Nucleic Acids Res 49(3):1688-1707 PMID: 33444449
- 5. Riabov Bassat D et al.. 2024. Structural basis of human U5 snRNP late biogenesis and recycling.. Nat Struct Mol Biol 31(5):747-751 PMID: 38467876
- 6. Boudreault S et al.. 2022. U5 snRNP Core Proteins Are Key Components of the Defense Response against Viral Infection through Their Roles in Programmed Cell Death and Interferon Induction.. Viruses 14(12) PMID: 36560714
- 7. Klimešová K et al.. 2021. TSSC4 is a component of U5 snRNP that promotes tri-snRNP formation.. Nat Commun 12(1):3646 PMID: 34131137
- 8. Ren T et al.. 2026. Neurochondrin promotes U5 snRNP maturation by regulating AAR2 release from PRPF8.. Nucleic Acids Res 54(13) PMID: 42411410
